公开(公告)号：US11787780B2

公开(公告)日：2023-10-17

申请号：US17353567

申请日：2021-06-21

申请人： CORCEPT THERAPEUTICS INCORPORATED

发明人： Hazel Hunt ,  Lorna Duffy ,  Ian Strutt ,  Morgan Jouanneau ,  Thomas Hornsby ,  Mark Mills ,  Andrew William Phillips ,  Jon-Paul Ward

IPC分类号： C07D401/14 ,  C07D403/04 ,  C07D403/12 ,  C07D403/14 ,  C07D231/56 ,  C07D409/14 ,  C07D413/14 ,  C07D487/04

CPC分类号： C07D401/14 ,  C07D231/56 ,  C07D403/04 ,  C07D403/12 ,  C07D403/14 ,  C07D409/14 ,  C07D413/14 ,  C07D487/04

摘要： The present disclosure provides compounds of Formula I or II. Compounds of Formula I or II may be used in pharmaceutical formulations, and may be used for modulating glucocorticoid receptors.

公开(公告)号：US12098141B2

公开(公告)日：2024-09-24

申请号：US18068857

申请日：2022-12-20

申请人： Corcept Therapeutics Incorporated

发明人： Lorna Duffy ,  Thomas Hornsby ,  Morgan Jouanneau ,  Mark Mills ,  Andrew William Phillips ,  Andrew James Smith ,  Hazel Joan Hunt ,  Peter Hunt

IPC分类号： C07D403/04 ,  C07D401/14

CPC分类号： C07D403/04 ,  C07D401/14

摘要： The present disclosure provides compounds of Formula I, Ia, Ib, Ib-1, Ib-2, Ic, Ic-1, Id-1, and Id-2. Compounds of Formula I, Ia, Ib, Ib-1, Ib-2, Ic, Ic-1, Id-1, and Id-2 may be used in pharmaceutical formulations, and may be used for modulating glucocorticoid receptors.

公开(公告)号：US20230242514A1

公开(公告)日：2023-08-03

申请号：US18068857

申请日：2022-12-20

申请人： Corcept Therapeutics Incorporated

发明人： Lorna Duffy ,  Thomas Hornsby ,  Morgan Jouanneau ,  Mark Mills ,  Andrew William Phillips ,  Andrew James Smith ,  Hazel Joan Hunt ,  Peter Hunt

IPC分类号： C07D403/04 ,  C07D401/14

CPC分类号： C07D403/04 ,  C07D401/14

摘要： The present disclosure provides compounds of Formula I, Ia, Ib, Ib-1, Ib-2, Ic, Ic-1, Id-1, and Id-2. Compounds of Formula I, Ia, Ib, Ib-1, Ib-2, Ic, Ic-1, Id-1, and Id-2 may be used in pharmaceutical formulations, and may be used for modulating glucocorticoid receptors.